Equipo de consultoría médica en oncología y hematología

Victor Angélico, MD
Director Médico Sénior

Victor Angélico, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Paris, France. He provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Angélico performs medical monitoring on assigned projects; reviews protocols, case report forms and other data and materials, and contributes to the scientific leadership of the Oncology area at Labcorp with a special focus in early phase clinical studies and hematological malignancies. Dr. Angélico is board-certified in Internal Medicine and Oncology with 16 years in the clinic and has significant medical and pharmaceutical expertise with 14 years of experience in the pharmaceutical industry. Before his current position, he served as Senior Medical Officer for Chiltern, France and as Medical Director at IQVIA France. Dr. Angelico joined Labcorp in January 2019.

Ariel E. Aguiló, MD
Director Médico Sénior

Ariel Aguiló, MD, Senior Medical Director for Labcorp Clinical Development Services in Buenos Aires, Argentina, is a board-certified oncologist specialized in gastrointestinal tumors.  Aporta su pericia en la materia y apoyo para el desarrollo y ejecución de ensayos clínicos en proyectos de desarrollo farmacológico de clientes, y además es el experto de la compañía en ensayos clínicos descentralizados (ECD). Dr. Aguiló performs medical monitoring on assigned projects, contributes to the medical strategy and execution of clinical programs, and brings scientific strategic leadership to the Oncology area at Labcorp.  Tiene 10 años de experiencia como médico, asesor médico y director médico en investigación y desarrollo farmacológicos. Before joining Labcorp, he served as Medical Director for Syneos Health in Buenos Aires, and prior to that, served as Medical Advisor for IQVIA in Buenos Aires. Dr. Aguiló began his career as Attending Physician, GI Oncology Department, Hospital de Gastroenterologia. He joined Labcorp in November 2019

Liliana Baila, MD
Directora Médica Sénior

Liliana Baila, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Brussels, Belgium.  Se desempeña como médica principal de proyecto en proyectos de desarrollo farmacológico de clientes. La Dra. Baila aporta sus conocimientos médicos/científicos a equipos de proyectos, se encarga de la monitorización médica y de seguridad en proyectos asignados, y desarrolla y evalúa protocolos, formularios de informes de casos y otros datos y materiales. La Dra. Baila tiene más de 25 años de experiencia como médica, investigadora médica y directora médica. Before joining Labcorp, she served as Clinical Research Physician for the European Organization for Research and Treatment of Cancer (EORTC) in Brussels.  La Dra. Baila inició su carrera como médica capacitándose en neonatología y pediatría en el Hospital Universitario en Rumania. She joined Labcorp in June 2020.

Maria Ignacia Berraondo, MD
Directora Médica Sénior

Maria Ignacia Berraondo, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Buenos Aires, Argentina. She provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Berraondo performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcrop. La Dra. Berraondo tiene más de 10 años de experiencia en hematología y como médica y asesora médica, con seis años en investigación clínica, incluso como directora en investigación y desarrollo clínicos. Before joining Labcrop, she served as Medical Director at IQVIA in Buenos Aires. Dr. Berraondo joined Labcrop in July 2020.

Stefanella Bortini, PhD, MD
Directora Médica Sénior

Stefanella Bortini, MD, PhD, is Senior Medical Director, Oncology, for Labcorp Clinical Development Services, based in Milano, Italy. She contributes to the development of Labcorp policies involving medical, safety and therapeutics, and serves as global lead project physician on assigned projects. Dr. Bortini brings more than 30 years of experience in clinical research to Labcorp. Antes de incorporarse a la compañía, se desempeñó como Directora Médica Sénior del área de Oncología en Chiltern International en Milán. También ocupó diferentes puestos en i3 Research, PRA International, Pharmacia & Upjohn y Eli Lilly. La Dra. Bonini tiene la certificación médica de la Junta italiana de examinadores médicos y cirujanos y tiene la certificación médica de ECFMG para EE. UU. Obtuvo su título de médica en la Universidad de Florencia en Italia y su PhD en Ingeniería Biomédica en la Universidad Northwestern. She joined Labcorp in July 2019.

Patricia Brandalise, MD, MsC
Clinical Oncologist

Patrícia Andrade Brandalise, M.D; MsC is a boarded clinical oncologist in Brazil since 2005. Dr. Brandalise earned her M.D. and MsC degrees at Campinas State University (UNICAMP), Brazil, and received her oncology qualifications in the Campinas Institute of Oncology. She is an active member of the Brazilian Society of Oncology. Dr. Brandalise has more than 18 years of experience in clinical oncology with clinical, investigational and administrative responsibilities and 15 years serving in pharmaceutical industry. Previously to joining LabCorp, Patrícia worked for Janssen and Abbvie as Medical Director for Latin America in the Hematology and Oncology Business Unit. She also served as Oncology Medical Leader for Roche Brazil implementing several compassionate use programs in Latin America, preparing, and delivering launches for new molecules/indications. She also has been designing and implementing Phase I-II-III-IV trials in Argentina, Brazil, Colombia, México, Peru, Argentina, Puerto Rico, Korea and Australia, many as lead physician. She joined Labcorp in April 2022.

Valery Chatikhine, MD, PhD

Valery is a medical oncologist (MD, PhD), board certified by University of Paris XI and Cancer Research Center of the Russian Academy Medical Science, with more than 10 years medical oncology clinical practice.

He is experienced in oncology drug development Phase 1-3 studies for multiple solid tumors and selected hematologic malignancies with small, large molecules (Immuno-Oncology), ADCs and T cells & NK cells in solid tumors, glioblastoma and lymphoma with FDA and EMA relevant IND/NDAs/BLA submission and approval involvement.

Also, Valery is well published with more than 40 publications in peers review journals (Journal of Clinical Oncology, American Journal of Clinical Oncology, European Journal of Clinical Oncology, Cancer Letters). He is an active member of American Society of Clinical Oncology (ASCO) & Society for Neuro-Oncology (SNO). He joined Labcorp in April 2022.

Isagani M. Chico, MD
Vice President and Global Therapeutic Head for Oncology

Isagani (Gani) M. Chico, MD, is Vice President and Global Therapeutic Head for Oncology, Labcorp Clinical Development Services, based in Gaithersburg, Maryland. Gani has >30 years of experience in Oncology clinical drug development from small and medium sized biotechnology companies, CROs and the FDA, focused on planning and execution global Oncology clinical development projects from early phase to post approval, leadership of cross-functional strategic teams within medical affairs and clinical development organizations, and management of pharmaceutical, academic and regulatory interactions. Gani earned his medical Degree from the University of the Philippines, completed his Internal Medicine residency at the Cook County Hospital in Chicago, Medical Oncology fellowship training at the National Institutes of Health in Bethesda, MD. He joined in Labcorp in July 2020.

Carolina Dutra, MD, MsC
Director Médico

Carolina Dutra, MD, MsC is Medical Director for Labcorp Clinical Development Services, based in Brazil. She is medical oncologist by training and provides clinical and medical expertise to project teams and other Labcorp departments to advance clients' drug development programs. Dr. Dutra performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcorp. Dr. Mateo has more than 15 years of experience as a physician and principal investigator. She joined Labcorp in May 2021.

Jose Espinoza
Senior Medical Director, Therapeutic Area/Oncology

Dr.Espinoza has over 20 years of experience in drug development, which includes enrolling patients into cancer trials, helping design and execute studies, medical monitoring and data analysis of global trials, interfacing with regulatory bodies, and working with biotech and pharmaceutical companies to refine drug development strategies. Worked at PIVOTAL with key opinion leaders to develop new protocols for the treatment of hematological malignancies with CAR T cells . Served as the global medical monitor (USA/EU) in the pivotal Phase 2 study for the accelerated approval of melflufen in relapsed/refractory multiple myeloma by the FDA in February 2021. Dr. Espinoza holds a double specialization: Clinical Oncology (1992-97) and Clinical Hematology & Bone Marrow Transplantation (1997-2001) and has more than 20 years of clinical experience as Consultant Onco-Hematologist at public hospitals in Spain and Ireland. He joined in Labcorp in October 2021.

José Daniel Fanjul Fuente, MD
Director Médico

Jose Daniel Fanjul Fuente, MD, is Medical Director, Oncology, for Labcorp Clinical Development Services, based in Madrid, Spain. He provides medical and scientific guidance and support to project teams and investigative sites on clients’ drug development projects, and reviews protocols, case report forms, clinical study reports and other data and materials.  El Dr. Fuente tiene más de 10 años de experiencia como médico y director médico en investigación y desarrollo clínico con especialización en oncología.  Antes de ocupar su actual puesto se desempeñó como director médico y ocupó roles gerenciales en oncología con IQVIA y Bristol Myers Squibb en Buenos Aires, Argentina.  En Bristol Myers Squibb, el Dr. Fuente estuvo a cargo de la dirección de actividades científicas que dieron impulso a la línea de productos del área terapéutica de oncología (Nivolumab y Ipilimumab). He joined Labcorp in October 2018.

Begoña de las Heras Garcia, MD
Directora Médica Sénior

Begoña de las Heras Garcia, MD, is Senior Medical Director, Oncology, for Labcorp Clinical Development Services, based in Madrid, Spain. She is board certified Medical Oncologist, by La Paz hospital, Madrid, Spain. Begoña joined Labcorp in 2016.  Se desempeña como médica de proyecto en proyectos de desarrollo farmacológico de clientes y aporta su pericia médica y científica a equipos de proyectos y equipos de desarrollo comercial. Además es supervisora de un grupo de médicos en el área terapéutica de Oncología. She brings more than 20 years of national and international clinical oncology research experience to Labcorp.  Antes de ocupar su puesto actual fue Directora Médica Ejecutiva de Fase Inicial para Chiltern en el RU.  También ocupó puestos en el área de Investigación Médica de Eisai en el RU y de varias organizaciones en España entre las que podemos nombrar a la OIC Pivotal, Pharma Mar, AstraZeneca y Bristol-Myers Squibb. She also, was oncologist consult in several hospitals in Spain, General Yagüe Hospital in Burgos, Ntra Sra. Del Prado Hospital in Talavera de la Reina (Toledo) and La Paz Hospital in Madrid.

Franklin Gaylis, MD, FACS
Urology Consultant

Franklin Gaylis, MD, FACS, is a Urology Consultant at Labcorp Drug Development. He also serves as Executive Medical Director of Unio Health Partners (UHP), the largest Urology group in California and as a voluntary Professor of Urology at the University of California, San Diego.

Dr. Gaylis is a fellow of the American College of Surgeons, member of the American Urological Association and diplomat of the American Board of Urology. He lectures nationally and internationally on the subject of medical quality and implementation science and is considered a leader in the field. His research has been published in clinical journals such as Urology, Journal of Urology, Urology Practice, American Journal of Medical Quality, and the New England Journal of Medicine. Dr. Gaylis' practice of more than 30 years has been focused on treating early and late stage prostate and bladder cancer including surgical procedures as well as clinical trials, Phase 1-4. He has participated in numerous clinical trials over the past 30 years, serving as PI in many and has 40 publications, 30 of which he is first author. Dr Gaylis has a deep interest in data mining from the EMR and oversees UHP's healthcare informatics program. He has experience with "big data" analytics and is exploring the feasibility for developing synthetic/external controls in Urology at Labcorp. Dr Gaylis provides Urological guidance for therapeutics, diagnostics and biomarker clinical trials and has conducted several advisory boards for sponsors seeking guidance regarding protocols in development. He joined in Labcorp in 2020.

Brian Hamilton, MD, PhD
Director Médico Sénior

Brian Hamilton, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Newton, Massachusetts. He serves as Labcorp Subject Matter Expert for cellular immune-oncology, CAR-T and gene therapy.  También es médico principal de proyectos globales en proyectos de desarrollo farmacológico de clientes.  El Dr. Hamilton tiene más de 35 años de experiencia en medicina pediátrica, inmunología, trasplante de células madre hematopoyéticas, e investigación y desarrollo clínicos. Before joining Labcorp, he served as Executive Medical Monitor for Chiltern International.  También ocupó puestos de nivel sénior como director médico, médico director, en asuntos reglamentarios e investigación clínica con Galena Biopharma, AstraZeneca, Onyx Pharmaceuticals, Wyeth Oncology y otras compañías farmacéuticas y biotecnológicas. Dr. Hamilton joined Labcorp in August 2018.

Konstantin Haradinov, MD
Director Médico

Konstantin Haradinov, MD, is Medical Director, Oncology, for Labcorp Clinical Development Services, based in Sofia, Bulgaria. He contributes to the development of Labcorp policies involving medical, safety and therapeutics; serves as global lead project physician and provides medical and safety monitoring on assigned projects; reviews medical data and provides clinical and medical expertise to project teams and other Labcorp departments, and performs safety trend analyses.  El Dr. Haradinov tiene más de 15 años de experiencia en investigación clínica como director médico y como médico/oncólogo. Before joining Labcorp, he served as Medical Officer, Oncology, for Chiltern International in Sofia, Bulgaria. Dr. Haradinov joined Labcorp in April 2019.

He Huang, MD
Director Médico Sénior

He Huang is Senior Director, Asia Pacific (APAC) for Labcorp Clinical Development Services, based in Shanghai, China. He brings more than 10 years of experience as a physician and researcher in oncology, respiratory therapy and drug development to Labcorp. Before joining Labcorp, He served as Disease Area Head, Oncology/GI, for Bristol-Myers Squibb in Shanghai. También se desempeñó como Gerente Sénior del área de Respiración en AstraZeneca, y como Director Médico del área de Oncología/Gastroenterología en Roche en Shangái. Recibió los premios Global Champion y  China CEO en AstraZeneca. He began career as Medical Oncologist at Affiliated Hospital of Tongji Medical College of Huazhong University of Science and Technology in Wuhan, China. He joined Labcorp in September 2019.

Adrianne Kelly, MD
Directora Médica Sénior

Adrianne Kelly, MD, is a Contracted Senior Medical Director for Labcorp Clinical Development Services, based in Princeton, New Jersey, and Chief Medical Officer of Jude, Peregrine and Kelly Consultants, LLC, in Bethesda, Maryland.  Se desempeña como médica principal de proyecto en proyectos de desarrollo farmacológico de clientes.  La Dra. Kelly aporta sugerencias médicas/clínicas para protocolos y planes de desarrollo clínico, aporta sus conocimientos para decidir la idoneidad de centros en cuanto a requisitos protocolares, se encarga del monitoreo médico de proyectos asignados, y capacita a equipos de proyectos.  Tiene más de 30 años de experiencia como médica, investigadora clínica y desarrolladora farmacológica enfocada en hematología/oncología.  La Dra. Kelly obtuvo su título en medicina en Georgetown University y ha recibido más de una docena de premios por su liderazgo en atención médica y logros académicos. Dr. Kelly joined Labcrop in August 2010.

Geoffrey Kannan, PhD, MD
Director Médico Sénior

Geoffrey Kannan, PhD, MD, is a Senior Medical Director in the Oncology Therapeutic Area for Labcorp Clinical Development Services, based in Princeton, New Jersey. El Dr. Kannan se desempeña como médico  líder a nivel global en proyectos de desarrollo farmacológico para clientes, donde aporta su experiencia médica y brinda su apoyo en el desarrollo; además, lleva a cabo ensayos clínicos. Dr. Kannan brings more than 10 years of experience as a physician and medical director to Labcorp, specializing in oncology and pediatrics. Before joining Labcorp, he practiced as Pediatric Hematologist/Oncologist and Pediatric Neuro-oncologist, affiliated with Children's National Medical Center. Anteriormente, se desempeñó como Instructor de Pediatría y Neuroncología Pediátrica en el Departamento de Neuroncología Pediátrica, Dana-Farber Cancer Institute/Boston Children's Hospital/Harvard Medical School.  The author or co-author of many peer-reviewed journal articles, presentations and abstracts, Dr. Kannan joined Labcorp in November 2018.

Carlo Lanza, MD, PhD
Director Médico Ejecutivo

Carlo Lanza, MD, PhD, is Executive Medical Officer for Labcorp Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase 1-4 clinical trials for Labcorp clients. Está al frente de programas de investigación de desarrollo traslacional precoz y en la primera fase con terapias específicas, con moléculas pequeñas, biológicas y génicas. El Dr. Lanza también supervisa el desarrollo de las estrategias de desarrollo en últimas etapas, entrega y aprobación de programas de registro.  Tiene más de 20 años de experiencia en investigación y desarrollo clínicos como médico y Director Médico, con especialización en Pediatría y Oncología. Before joining Labcorp, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland. El Dr. Lanza también ha ocupado puestos ejecutivos en Novartis Oncology, Pfizer Global R&D y AstraZeneca UK. Carlo joined Labcorp in 2012.

Zarah Dulce Lucas, MD
Director Médico Sénior

Zarah Dulce Lucas, MD, is a Senior Medical Director in the Oncology Therapeutic Area for Labcorp Clinical Development Services, based in Princeton, New Jersey. Dr. Lucas serves as global lead project physician on clients' drug development projects, performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Labcorp. Dr. Lucas brings more than 10 years of experience as a physician, specializing in internal medicine, medical oncology and hematology. Prior to joining Labcorp in 2021, she practiced General Medical Oncology, Benign and Malignant Hematology at Northern Light Eastern Maine Medical Center and also served as principal investigator for several clinical trials, mostly breast cancer studies. She joined Labcorp in January 2022.

Wojciech Massalski, MD
Director Médico

Wojciech Massalski, MD, is Medical Director for Labcorp Clinical Development Services, based in Maidenhead, United Kingdom.  Se desempeña como médico principal de proyectos globales en proyectos de clientes y aporta su pericia para el desarrollo y ejecución de ensayos clínicos.  Esto incluye evaluar la idoneidad de centros de investigación y reclutamiento de participantes de ensayos, realizar evaluaciones de riesgos y monitorizar la seguridad de los datos en proyectos asignados.  El Dr. Massalski tiene más de 20 años de experiencia como médico, investigador médico y director médico. Before Labcorp, he was Senior Medical Officer for Chiltern International in the UK.  También ocupó puestos de investigación clínica y monitorización médica con Pfizer y Synexus Limited en el RU. Dr. Massalski joined Labcorp in April 2019.

Maksym Novikov, MD
Director Médico Sénior

Maksym Novikov, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Maidenhead, United Kingdom. He serves as global lead project physician on assigned projects, providing medical expertise and support in the development and conduct of clinical trials. This includes reviewing feasibility of investigator sites and recruitment of trial subjects and performing feasibility risk assessment and data safety monitoring, develops and reviews protocols, case report forms and other data and materials on assigned projects. Dr. Novikov has more than 20 years of experience as a physician (surgeon), clinical researcher and medical director. Before Labcorp, he was Senior Medical Officer for Chiltern International in the UK. He also has held clinical research and medical monitoring positions with Novartis, AstraZeneca and other drug development and health care organizations. He joined Labcorp in April 2019.

Valery Novikov, MD, PhD
Directora Médica Sénior

Valery Novikov, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Paris, France.  Se encarga de la estrategia y ejecución médica de proyectos de investigación clínica de clientes.  La Dra. Novikov evalúa protocolos, formularios de informe de casos, informes de ensayos clínicos, nuevas aplicaciones farmacológicas, valores de laboratorio, eventos adversos, cuadros de datos y otros materiales de datos.  También se encarga de la monitorización médica y de seguridad en proyectos asignados. She brings more than 20 years of national and international clinical research experience to Labcorp. Before joining Labcorp, Dr. Novikov served as Clinical Study Director for Sanofi in France.  También ocupó puestos en investigación clínica con Generium, Helios Clinical Research y PRA International en Moscú, Rusia. Dr. Novikov joined Labcorp in August 2019.

Maria Parellada, MD
Director Médico

Maria Elvira Parellada, MD, is Medical Director for Labcorp Clinical Development Services, based in Buenos Aires, Argentina. She provides subject matter expertise in Hematology, supporting development of clinical trials and drug development. Dr. Parellada performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials. Dr. Parellada has 10 years of experience as an hematologist physician; four years in clinical research, as investigator in several clinical trials including acute, chronic myeloproliferative and lymphoproliferative disorders; and currently as medical director in clinical research and development. She is a member of Argentinian Society of Hematology. Before joining Labcorp, she served as MSL Hematology for Janssen Pharmaceutical, at Argentina . She joined Labcorp in August 2021.

Martine Poelman, MD
Directora Médica Ejecutiva

Martine Poelman is Executive Medical Director, Oncology, for Labcorp Clinical Development Services, based in Brussels, Belgium. She provides medical and scientific support to help advance drug development in hematological malignancies for Labcorp clients. Martine brings more than 30 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology, to Labcorp. Before assuming her current position, Martine served more than 15 years as Global Head of Oncology Research for Labcorp, providing medical monitoring for more than 200 clinical trials. Before joining Labcorp, she served as Clinical Research Physician, Hemato-Oncology-Infectiology, for Eli Lilly in Brussels. Antes de dedicarse a la investigación, se desempeñó como médica especialista en trasplante de médula ósea y en hematología y oncología en el Departamento de Oncología Pediátrica de Wilhelmina Children's Hospital, en Holanda. Martine joined Labcorp in November 1996.

Chia Portera, MD, PhD
Directora Médica Sénior

Chia Portera, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services, based in Princeton, New Jersey.  Se encarga de evaluar y establecer estrategias de desarrollo farmacológico para proyectos de investigación de clientes y aporta su pericia científica y clínica a equipos de proyectos. La Dra. Portera desarrolla, evalúa y revisa protocolos, informes de ensayos clínicos, aplicaciones de fármacos nuevos y otros datos y documentos, y se encarga de la monitorización médica y de seguridad en proyectos asignados.  Cuenta con más de 10 años de experiencia como oncóloga médica y directora médica en investigación y desarrollo clínicos. As a medical director at Genentech before joining Labcorp, Dr. Portera led clinical development strategies of post-market therapies for treatment of HER2+ breast cancer. She joined Labcorp in July 2015.

Kamal Veer Singh Saini, MD
Director Médico Ejecutivo

Kamal Veer Singh Saini, MD, is Executive Medical Director, Oncology, for Labcorp Clinical Development Services, based in Brussels, Belgium.  Kamal es oncólogo médico certificado por la junta con licencia vigente para ejercer la profesión en el RU. He contributes to the scientific strategic leadership of the Oncology area at Labcorp, and provides clinical and medical expertise to project teams and other Labcorp departments on clients' drug development projects. Kamal brings more than 15 years of experience in clinical research and development to Labcorp.  Anteriormente se desempeñó como Subdirector Científico de una organización de investigación académica y como Asesor Médico del Institute Jules Bordet en Bruselas. The author or co-author of several peer-reviewed journal articles, Kamal joined Labcorp in June 2015.

Irina Savina, MD, PhD
Director Médico

Irina Savina, MD, PhD, is Medical Director for Labcorp Clinical Development Services in Saint-Petersburg, Russian Federation. She serves as lead project physician on clients' drug development projects, provides medical/scientific expertise to project teams, reviews protocols and medical data, and is responsible for medical and safety monitoring on assigned projects. Dr. Savina has more than 27 years of experience as a physician, research clinician and medical director with therapeutic experience in oncology. Before joining Labcorp, she was Medical Oncologist, Lower Gastrointestinal surgeon, in Saint-Petersburg. She joined Labcorp in February 2010.

Maya Ma Seunghyun, MD
Director Médico

Seunghyun Ma, MD, is a Medical Director at Labcorp Clinical Development Services, Seoul, South Korea. She supports clients by serving as a project physician, providing medical expertise & insights, and contributing to the development and implementation of complex clinical trials. Before joining Labcorp, she was the Therapeutic Area Head, Oncology at AbbVie. Previously, she was a clinical research physician at Eli Lilly and Novartis. She had substantial experience as a physician and cancer epidemiologist and in conducting oncology-related cohort studies such as phase 4 clinical trials. She has been an author/co-author of more than two dozen articles in eminent journals. She joined in July 2021

Ivana Teodorovic, MD
Directora Médica Sénior

Ivana Teodorovic, MD, is Senior Medical Director for Labcorp Clinical Development Services, based in Brussels, Belgium. Dr. Teodorovic serves as project physician and provides scientific support on global and regional oncology studies for Labcorp clients. Desarrolla, examina y revisa los protocolos,  coordina y lleva a cabo monitoreos médicos, y revisa los datos de los pacientes. La Dra. Teodorovic tiene más de 30 años de experiencia como médica y Directora Médica experta en investigación y desarrollo farmacológicos. Before joining Labcorp, she served more than 10 years as Coordinating Physician for the European Organization for Research and Treatment of Cancer Data Center Company (EORTC) in Brussels, where she authored the SOP-EORTC Tissue Research Policy. La Dra. Teodorovic comenzó su carrera como anatomopatóloga matriculada en el Institute for Oncology and Radiology en Belgrado, Serbia.  She joined Labcorp in May 2005.

Laura Vidal, MD
Directora Médica Ejecutiva

Laura Vidal, MD, is Executive Medical Director for Labcorp Clinical Development Services, based in Madrid, Spain. Dr. Vidal is the Medical Head of the Oncology group in EU. She contributes to the development of Labcorp policies involving medical, safety and therapeutics; serves as point of contact for key clients on business oversight; manages relationships with investigators/sites for clinical trials, and mentors clinical research physicians and medical directors across the company. La Dra. Vidal tiene más de 15 años de experiencia como médica, oncóloga clínica y directora médica. Before joining Labcorp, she was Executive Medical Director for Syneos Health in Madrid, and previously served as a physician, medical oncologist, and clinical trials coordinator for a hospital in Barcelona.  La Dra. Vidal es autora o coautora de docenas de artículos publicados en revistas especializadas revisados por pares y ha recibido numerosos premios de salud e investigación. She joined Labcorp in December 2020.

Liang Wan, MD, PhD
Director Médico

Liang Wan, MD, PhD, is Medical Director for Labcorp Clinical Development Services in Shanghai, China. He serves as lead project physician on clients' drug development projects, provides medical/scientific expertise to project teams, reviews protocols and medical data, and is responsible for medical and safety monitoring on assigned projects.  El Dr. Wan tiene más de 25 años de experiencia como médico, investigador médico y director médico con experiencia terapéutica en oncología, gastroenterología y hematología. Before joining Labcorp, he was Medical Director for IQVIA in Shanghai, serving as Global or Regional Medical Advisor on assigned projects.  Empezó su carrera como cirujano e investigador clínico en el Hospital Rui Jin de la Universidad Jiao Tong de Shanghái. Dr. Wan joined Labcorp in May 2019.

Howard Yeh, MD
Director Médico Sénior

Howard Yeh, MD, es Director Médico Sénior (Los Ángeles, CA) en Princeton, Nueva Jersey. Se encarga de presentar las prestaciones médicas/científicas a clientes y participa en conversaciones sobre factibilidad en cuanto a propuestas de proyectos, forja relaciones con los clientes y con investigadores/centros para ensayos clínicos, y se desempeña como médico principal en proyectos de desarrollo farmacológico de clientes. El Dr. Yeh tiene más de 15 años de experiencia como director médico en investigación clínica y desarrollo farmacológico. Before joining Labcorp, he was Medical Director for Johnson and Johnson, Janssen Oncology Clinical Development Services, in Pennsylvania. Antes también fue Director Médico en Amgen Clinical Development Services en California. The author or co-author of nearly two dozen peer-reviewed journal articles, Dr. Yeh joined Labcorp in May 2016.

Reigetsu Yoshikawa, MD, PhD
Directora Médica Sénior

Reigetsu Yoshikawa, MD, PhD, is Senior Medical Director for Labcorp Clinical Development Services in Osaka, Japan. She contributes to the development of medical strategies and execution of clients' clinical programs and provides medical/scientific expertise to project teams. Dr. Yoshikawa has more than 30 years of experience as a physician, medical director/advisor, and professor of medicine in Japan. Before joining Labcorp, she was Senior Medical Advisor for Eli Lilly and previously served as Senior Medical Lead for Dainippon Sumitomo Pharma in Japan. Dr. Yoshikawa has served on the editorial boards of several peer-reviewed journals and has authored or co-authored dozens of articles, presentations, and abstracts. She joined Labcorp in January 2021.